Company intelligence / Profile preview
Beijing Neo-Immune Biotech
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing Neo-Immune Biotech is a clinical-stage biotechnology company specializing in personalized cancer immunotherapy. The company leverages its proprietary AI-driven platform, iNeo, to identify and design patient-specific neoantigens for therapeutic use. Its primary focus is the development of personalized neoantigen vaccines and T-cell therapies targeting various solid tumors, including pancreatic and lung cancers. By integrating bioinformatics with immunology, the company aims to provide precision medicine solutions that enhance the immune system's ability to recognize and eliminate malignant cells.
- Therapeutic areas
- Oncology
- Modalities
- VaccinePeptidesCell therapymRNA-based drugsT cell therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Peking Union Medical College HospitalZhejiang University
Beyond the preview
Go deeper on Beijing Neo-Immune Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Neo-Immune Biotech.